Tag: Biodesix financing,Press Releases
-
Biodesix Raises Follow-On Series F Financing
Biodesix, Inc., a molecular diagnostics company that discovers, develops and commercializes blood tests to deliver personalized medicine in oncology, announced today that the company increased the size of its offering of series F preferred shares in a follow-on sale, raising an additional $7 million.